Neuphoria Therapeutics Inc. (NEUP)

Neuphoria Therapeutics Revenue

Neuphoria Therapeutics had revenue of $-13.27K in the twelve months ending March 31, 2026. In the fiscal year ending June 30, 2025, Neuphoria Therapeutics had annual revenue of $15.65M.

• Revenue (ttm): $-13.27K
• Revenue Growth: n/a
• P/S Ratio: -1,938.24
• Revenue / Employee: n/a
• Employees: 8
• Market Cap: 25.71M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	15.65M	-	-
Jun 30, 2024	-	-	-
Jun 30, 2023	-	-	-
Jun 30, 2022	4.17M	3.48M	499.60%
Jun 30, 2021	695.81K	-1.37M	-66.32%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 19, 2026

Data Sources Report a data error